SAB Biotherapeutics, Inc. (SABS)
3.71
-0.08
(-2.11%)
USD |
NASDAQ |
Aug 31, 16:00
3.715
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics EPS Diluted (Quarterly) : -0.282 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.282 |
| March 31, 2026 | -0.3523 |
| December 31, 2025 | -0.8134 |
| September 30, 2025 | -0.2126 |
| June 30, 2025 | -1.088 |
| March 31, 2025 | -0.5593 |
| December 31, 2024 | -1.228 |
| September 30, 2024 | -1.118 |
| June 30, 2024 | -0.7926 |
| March 31, 2024 | -0.5438 |
| December 31, 2023 | -3.856 |
| September 30, 2023 | -0.9736 |
| Date | Value |
|---|---|
| June 30, 2023 | -1.365 |
| March 31, 2023 | -1.459 |
| December 31, 2022 | -1.563 |
| September 30, 2022 | -1.644 |
| June 30, 2022 | -1.111 |
| March 31, 2022 | 0.2152 |
| December 31, 2021 | -4.044 |
| September 30, 2021 | -1.564 |
| June 30, 2021 | -1.133 |
| March 31, 2021 | 0.5022 |
| December 31, 2020 | -0.0061 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.49M |
| Total Expenses (Quarterly) | 22.49M |
| Enterprise Value | 212.26M |
| Earnings Yield | -44.75% |
| Normalized Earnings Yield | -58.72 |